{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:05:35Z","timestamp":1775898335317,"version":"3.50.1"},"reference-count":20,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Photoderm Photoimm Photomed"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:p><jats:bold>Background: <\/jats:bold> In recent years, narrow\u2010band ultraviolet B (NB\u2010UVB, 311\u2013313\u2003nm) has been found to be beneficial for early\u2010stages mycosis fungoides (MF). The aim of this study is to investigate the effect of NB\u2010UVB in 20 patients with early\u2010stage MF.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> Twenty patients (10 women and 10 men, mean age 54 \u00b1 22 years) with clinically and histologically confirmed MF were enrolled in the study. All of the patients had clinical stage I disease (T1 or T2, N0, M0) with cutaneous involvement, consisting of patch\u2010stage disease of limited extent, in 50% of the cases (stage IA), and more widespread in the other 50% (stage IB). All the patients were treated with NB\u2010UVB therapy until more than 95% clearance of the patient's skin lesions had occurred.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> A complete response was achieved in 90% of the cases after a mean of 29 \u00b1 14 treatments within a mean period of 4 months (range 1\u20138 months), with an average cumulative dose of 25 \u00b1 16.77\u2003J\/cm<jats:sup>2<\/jats:sup>. In the follow\u2010up period, relapse occurred after a mean period of 8 months (range 3\u201317 months), and then therapy was restarted.<\/jats:p><jats:p><jats:bold>Conclusion: <\/jats:bold> This study provides evidence that NB\u2010UVB might be an efficient option for stage IA and IB MF patients.<\/jats:p>","DOI":"10.1111\/j.1600-0781.2007.00314.x","type":"journal-article","created":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T07:08:37Z","timestamp":1193900917000},"page":"229-233","source":"Crossref","is-referenced-by-count":30,"title":["Narrow\u2010band ultraviolet therapy in early\u2010stage mycosis fungoides: study on 20 patients"],"prefix":"10.1111","volume":"23","author":[{"given":"V.","family":"Brazzelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Antoninetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Palazzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Prestinari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Borroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,11]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"322","article-title":"Retinoids","volume":"16","author":"Zhang C","year":"2003","journal-title":"therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma"},{"key":"e_1_2_6_3_2","first-page":"565","article-title":"UVB in management of early stage of mycosis fungoides","volume":"20","author":"Pavlotsky F","year":"2006","journal-title":"JEADV"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.03.012"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.6.748"},{"key":"e_1_2_6_6_2","first-page":"215","article-title":"Narrow\u2010band UVB and psoralen\u2010UVA in the treatment of early\u2010stage mycosis fungoides","volume":"48","author":"Diederen PVMM","year":"2003","journal-title":"a retrospective study"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1396-0296.2003.01642.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.11.1377"},{"key":"e_1_2_6_9_2","first-page":"725","article-title":"Report of the committee on staging and classification of cutaneous T\u2010cell lymphoma","volume":"63","author":"Bunn PJ","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_6_10_2","first-page":"234","article-title":"Treatment of mycosis fungoides with photochemotherapy (PUVA)","volume":"33","author":"Herrmann JJ","year":"1995","journal-title":"long-term follow-up"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120911"},{"key":"e_1_2_6_12_2","first-page":"804","article-title":"Narrow\u2010band UVB phototherapy for early\u2010stage mycosis fungoides","volume":"20","author":"G\u00f6kdemir G","year":"2006","journal-title":"evaluation of clinical and histopathological changes"},{"key":"e_1_2_6_13_2","first-page":"755","article-title":"The photocarcinogenic risk of narrow\u2010band UVB (TL\u201001) phototherapy","volume":"152","author":"Man I","year":"2005","journal-title":"early follow-up data"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.08.047"},{"key":"e_1_2_6_15_2","first-page":"370","article-title":"No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy","volume":"84","author":"Weischer M","year":"2004","journal-title":"a first retrospective study"},{"key":"e_1_2_6_16_2","first-page":"566","article-title":"Photocarcinogenic risk of narrowband ultraviolet B (TL\u201001) phototherapy","volume":"154","author":"Black RJ","year":"2006","journal-title":"early follow-up data"},{"key":"e_1_2_6_17_2","first-page":"237","article-title":"Photocarcinogenicity of psoralens used in PUVA treatment","volume":"6","author":"Young AR.","year":"1990","journal-title":"present status in mouse and man"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02898.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2003.08.019"},{"key":"e_1_2_6_20_2","first-page":"99","article-title":"Biological effects of narrow\u2010band (311\u2003nm TL01) UVB irradiation","volume":"38","author":"El\u2010Ghorr AA","year":"1997","journal-title":"a review"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.4.711"}],"container-title":["Photodermatology, Photoimmunology &amp; Photomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0781.2007.00314.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0781.2007.00314.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T16:48:10Z","timestamp":1697302090000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0781.2007.00314.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1111\/j.1600-0781.2007.00314.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0781.2007.00314.x","archive":["Portico"],"relation":{},"ISSN":["0905-4383","1600-0781"],"issn-type":[{"value":"0905-4383","type":"print"},{"value":"1600-0781","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}